Serratus Anterior Plane Block and Costotransverse Block for Analgesia Following Modified Radical Mastectomy Surgeries

Launched by AIN SHAMS UNIVERSITY · Feb 7, 2024

Keywords

ClinConnect Summary

This clinical trial is studying two methods of pain relief for women undergoing a type of breast surgery called modified radical mastectomy (MRM). The goal is to find out which method—either a single injection to block pain in a specific area or another injection to block pain along the spine—works better for managing pain after surgery. This is important because effective pain management can help patients move around and feel better sooner after their surgery.

To participate in this study, women aged 18 to 75 who are in good health (Class I or II according to the American Society of Anesthesiologists) and scheduled for MRM may be eligible. However, those who have certain medical conditions, allergies to the medications used, or who regularly take strong pain medications may not qualify. Participants can expect to receive one of the pain relief methods as part of their overall care plan and will be monitored for safety and effectiveness. This trial aims to improve pain management options for patients undergoing breast cancer surgery.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. American Society of Anaesthesiologists (ASA) Physical Status Class I, II.
• • 2. Scheduled for modified radical mastectomy (MRM).
• • 3. Body weight ranging from 60 to 100 kilograms.
• Exclusion Criteria:
• • 1. Declining to give a written informed consent.
• • 2. History of allergy to the medications used in the study.
• • 3. Contraindications to regional anesthesia (including patient: refusal, coagulopathy, and local infection).
• • 4. Psychiatric disorders.
• • 5. Significant cognitive dysfunction.
• • 6. American Society of Anesthesiologists (ASA) Physical Status Class III and IV.
• • 7. Daily use of opioids.
• • 8. Obesity (BMI \> 35 kg/m2).